Jon Zugazagoitia, MD, PhD

Attending Physician-Scientist in Medical Oncology
Department of Medical Oncology, 12 de Octubre Hospital, Spain

Poster(s):

• (301) Zongertinib in patients with pretreated human epidermal growth factor receptor 2-mutant advanced non–small cell lung cancer: Beamion LUNG-1
  Wednesday, October 29, 2025